Publication
A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol.
Journal Paper/Review - Jan 15, 2024
Mastall Maximilian, Roth Patrick, Bink Andrea, Maranta Angela Fischer, Läubli Heinz, Hottinger Andreas Felix, Hundsberger Thomas, Migliorini Denis, Ochsenbein Adrian F, Seystahl Katharina, Imbach Lukas L, Hortobágyi Tibor, Held Leonhard, Weller Michael, Wirsching Hans-Georg
Mastall, Maximilian
Roth, Patrick
Bink, Andrea
Maranta, Angela Fischer
Läubli, Heinz
Hottinger, Andreas Felix
Hundsberger, Thomas
chief of serviceNeurologie, Medizinische Onkologie und Hämatologie · Dept. III, Dept. I